The aim of the multi-centre study is to evaluate correctly the impact of three dimensional visualization on operation strategy and complications for complex hepatic carcinoma.
Because of the complexity of complex hepatic carcinoma,the limitations of 2D images of CT/MRI and the uncertainty of surgeons'experience, it is difficult for the surgeons to diagnosis and assess the operation strategy accurately based on traditional 2D imaging(CT/MRI).The aim of the multi-centre study is to evaluate correctly the impact of three-dimensional visualization on operation strategy and complications for complex hepatic carcinoma.
Study Type
OBSERVATIONAL
Enrollment
2,000
Zhujiang Hospital of The Southern Medical University
Guangzhou, Guangdong, China
RECRUITINGImpact on operation strategy of three dimensional visualization technique
Firstly, the operation strategies based on original CT or MRI image data will be made by the team, Secondly, the operation strategies based on three dimensional reconstruction models will be made by the team, then, actually surgical strategies will be recorded. The change of operation strategy will be assessed by comparing the strategy of the 2D model and 3D model. The change rate of operation strategy will be recorded and presented as percentage.
Time frame: 2 year
Impact on complication of three dimensional visualization technique
The complications are refer to the classification of Clavien-Dindo, including postoperative bleeding, biliary fistula, ascites, postoperative liver failure, renal dysfunction, pleural effusion, abdominal cavity infection, abdominal abscess, incision infection, the occurrence cases of each complication (number) will be recorded.
Time frame: 2 year
Blood routine examination (the 1th, 3 th, 5th, 7th)
Hemoglobin (g/L), Platelet(109/L), and neutrophilic granulocyte percentage (%)
Time frame: 2 year
Urine routines (the 1th, 3 th,5th, 7th)
Urine specific gravity, urine protein(mg/dl), urine sugar(mmol/L), leukocytes in urine(number/ul), urine erythrocyte(number/ul)
Time frame: 2 year
Stool Routine (the 1th, 3 th,5th, 7th)
Defecate occult blood test, Microorganisms (mold, parasites, etc.)
Time frame: 2 year
Blood biochemistry (the 1th, 3 th,5th, 7th)
Serum albumin(g/L), serum pre-albumin(g/L), serum globulin(g/L), total bilirubin(µmol/L), direct bilirubin(µmol/L),serum glutamic-oxaloacetic transaminase (AST, IU/L), serum glutamic pyruvic transaminase (ALT, IU/L), alkaline phosphatase (ALP, IU/L), gamma glutamyl transpeptidase(r-GGT, IU/L) ,Serum creatinine(µmol/L), Urea(mmol/L), Blood sugar(mmol/L)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 2 year
Tumor marker
Alpha fetoprotein(AFP, ng/L), Carbohydrate antigen-199(CA-199, ku/L), Carbohydrate antigen-125(CA-125, ku/L), Carcinoembryonic antigen (CEA, ng/L), Carbohydrate antigen-153(CA-153, ku/L)
Time frame: 2 year
The blood coagulation function (the 1th, 3th, 5th, 7th)
prothrombin time (PT, s), partial thromboplastin time (APTT), international normalized ratio (INR), plasma prothrombin activity (PTA, %), fibrinogen (FIB, g/L), d-dimer(mg/L)
Time frame: 2 year
Inflammatory biomarkers
C-reactive protein, procalcitonin
Time frame: 2 year
Preoperative viral loading
HBV- DNA、HCV- RNA
Time frame: 2 year
Postoperative results of paraffin wax and immunohistochemical index
AFP、Ki67、CK18、CK19、Hepatocyte
Time frame: 2 year